In recent years, neurobiochemical markers of brain damage
|
|
- Bertha Hunt
- 5 years ago
- Views:
Transcription
1 Early Neurobehavioral Outcome After Stroke Is Related to Release of Neurobiochemical Markers of Brain Damage Michael T. Wunderlich, MD; Anne D. Ebert, PhD; Torsten Kratz, MD; Michael Goertler, MD; Stefan Jost, MD; Manfred Herrmann, MD, PhD Background and Purpose The study aimed to investigate the predictive value of neurobiochemical markers of brain damage (protein S-100B and neuron-specific enolase [NSE]) with respect to early neurobehavioral outcome after stroke. Methods We investigated 58 patients with completed stroke who were admitted to the stroke unit of the Department of Neurology at Magdeburg University. Serial venous blood samples were taken after admission and during the first 4 days, and protein S-100B and NSE were analyzed by the use of immunoluminometric assays. In all patients, lesion topography and vascular supply were analyzed and volume of infarcted brain areas was calculated. The neurological status was evaluated by a standardized neurological examination and the National Institutes of Health Stroke Scale (NIHSS) on admission, at days 1 and 4 on the stroke unit, at day 10, and at discharge from the hospital. Comprehensive neuropsychological examinations were performed in all patients with first-ever stroke event and supratentorial brain infarctions. Functional outcome was measured with the Barthel score at discharge from the hospital. Results NSE and protein S-100B concentrations were significantly correlated with both volume of infarcted brain areas and NIHSS scores. Patients with an adverse neurological outcome had a significantly higher and significantly longer release of both markers. Neuropsychological impairment was associated with higher protein S-100B release, but this did not reach statistical significance. Conclusions Serum concentrations and kinetics of protein S-100B and NSE have a high predictive value for early neurobehavioral outcome after acute stroke. Protein S-100B concentrations at days 2 to 4 after acute stroke may provide valuable information for both neurological status and functional impairment at discharge from the acute care hospital. (Stroke. 1999;30: ) Key Words: health status nerve tissue neuron-specific enolase neuropsychology outcome protein S-100 stroke In recent years, neurobiochemical markers of brain damage gained particular attention in the identification of stroke patients with an adverse neurological outcome. Neuronspecific enolase (NSE) and protein S-100B are the markers of brain damage that have been studied most often in clinical and experimental settings. Protein S-100B forms part of a large and diverse family of Ca 2 -binding proteins predominantly found in astrocytes and Schwann cells, 1,2 and NSE, a dimeric isoenzyme of the glycolytic enzyme enolase, is found in the cytoplasm of neurons and cells with neuroendocrine differentiation. 3,4 Both protein S-100B and NSE are considered specific neurobiochemical markers of brain damage after brain infarctions in humans 5 8 or in animals 9 11 and after brain damage caused by traumatic brain injury or by cardiac surgery During the last few years, several studies 5,6,8,18 21 have investigated release and kinetics of protein S-100B and/or NSE after acute stroke and their association with lesion volume, clinical status, and outcome. Because of small sample sizes and different approaches to the analysis of neurobiochemical markers (concentrations in cerebrospinal fluid versus peripheral blood), the results are heterogeneous. Furthermore, the majority of studies focus on severe neurological deficits after stroke. The purpose of the present study was to investigate the relation between release patterns and serum concentrations of protein S-100B and NSE and early neurobehavioral outcome after stroke in a well-characterized group of patients. Our objectives were (1) to analyze the correlation of neurobiochemical markers and volume of infarcted brain areas and (2) to evaluate the association of NSE and protein S-100B with early neurological, neuropsychological, and functional outcome after stroke. Subjects and Methods Subjects From a consecutive series of 81 patients with acute stroke admitted to the stroke unit of the Department of Neurology between February and September 1998, 58 patients were included in the study. Criteria Received January 8, 1999; final revision received March 8, 1999; accepted March 18, From the Division of Neuropsychology and Behavioral Neurology (M.T.W., A.D.E., T.K., M.H.) and Department of Neurology (M.G., S.J.), Otto-von-Guericke University, Magdeburg, Germany. Correspondence to Manfred Herrmann, MD, PhD, Division of Neuropsychology and Behavioral Neurology, Otto-von-Guericke University, Leipziger Str 44, D Magdeburg, Germany. manfred.herrmann@medizin.uni-magdeburg.de 1999 American Heart Association, Inc. Stroke is available at
2 Wunderlich et al June TABLE 1. for exclusion were hemorrhagic stroke or ischemic brain infarctions in the course of cerebral hemorrhage and concomitant major cardiac, renal, hepatic, and tumor diseases potentially interfering with standardized assessment of neurological or neuropsychological status. Table 1 shows demographic, clinical, and neuroradiological data as well as information on subtypes of cerebral infarctions 22 and etiology. 23 Forty-three patients suffered from supratentorial infarctions, and 15 patients exhibited cerebellar or brain stem infarctions. Thirty patients had a first single and unilateral supratentorial stroke. The mean time between the onset of stroke and admission to the stroke unit was 6.9 hours ( 13.7). Methods Demographic, Clinical, and Neuroradiological Data Supratentorial Infarctions Infratentorial Infarctions No. of patients (%) 43 (74) 15 (26) Age, mean (SD), y 67 ( 14.4) 62 ( 11.1) Sex, male/female, No. (%) 24 (56)/19 (44) 12 (80)/3 (20) Time to admission, mean (SD), h 6 ( 5.4) 12 ( 7.0) NIHSS score on admission, mean (SD) 9.9 ( 8.8) 3.3 ( 2.4) NIHSS score day 1, mean (SD) 9.9 ( 9.0) 2.1 ( 1.9) NIHSS score day 4, mean (SD) 6.6 ( 6.9) 1.7 ( 1.8) NIHSS score day 10 12, mean (SD) 3.9 ( 6.6) 1.0 ( 1.2) Barthel score on discharge, mean (SD) 68.5 ( 37.5) 92 ( 11.6) Lesion location, left/right, No. (%) 23 (53)/20 (47) 12 (80)/3 (20) Frontal 5 (12)/6 (14) Parietal 9 (21)/9 (21) Temporal 12 (28)/11 (26) Occipital 1 (2)/3 (7) Basal ganglia 7 (16)/7 (16) Thalamus 2 (5)/1 (2) Brain stem 7 (47)/3 (20) Cerebellum 5 (33)/0 (0) Lesion volume, mean (SD), ml (n 58) 36.6 ( 90.2) 7.6 ( 15.3) Stroke subtypes, No. (%) LACI 9 (15.5) TACI 12 (20.7) PACI 15 (25.9) POCI 15 (25.9) Not classifiable 7 (12.1) Etiology, No. (%) Cardioembolism 21 (36.2) Small-artery occlusion 10 (17.2) Large-artery atherosclerosis 10 (17.2) Undetermined 17 (29.3) LACI indicates lacunar infarcts; TACI, total anterior circulation infarcts; PACI, partial anterior circulation infarcts; and POCI, posterior circulation infarcts. *According to Bamford et al. 22 According to the TOAST criteria. 23 Neurobiochemical Examinations Serial venous blood samples were collected at admission (t 0 : mean time after stroke onset, hours; n 52), and at days 1 (t 1 : hours; n 56), 2 (t 2 : hours; n 55), 3 (t 3 : hours; n 49), and 4 (t 4 : hours; n 47) after admission to the stroke unit. Blood was allowed to clot, and after centrifugation within 30 minutes (1000g, 10 minutes), serum was stored at 80 C for later analysis. Serum protein S-100B and NSE were analyzed by the use of immunoluminometric assays and a fully automated LIA-mat system (Byk-Sangtec Diagnostica). Sangtec 100 measures the -subunit of protein S-100 as defined by 3 monoclonal antibodies. The detection limit of the kit is 0.02 g/l, and the range of protein S-100B serum concentrations of healthy subjects is reported to be 0.12 g/l. NSE measurement is based on monoclonal antibodies that bind to the -subunit of the enzyme, and the minimal measurable concentration is 1.0 g/l. Neuroradiological Examinations All neuroradiological examinations were based on cranial CT scans. All scans were performed in standardized slices without contrast enhancement soon after admission (mean, hours after infarction) and were repeated within the first week (mean, hours after infarction). We analyzed the cranial CT data of all subjects using the public domain NIH Image program (developed at the US National Institutes of Health and available on the Internet at Lesions were evaluated with respect to lesion topography (on the basis of Damasio and Damasio 24 and Matsui and Hirano 25 ) and territories of vascular supply (according to Damasio and Damasio, 24 including the territories of the deep perforators of the carotid system of Ghika et al 26 ). Neuroradiological evaluations were performed independently by 2 members of our group (M.T.W. and T.K.); 1 of them (T.K.) was blind to all other data. The mean difference of the calculation of lesion volume between evaluators was 1.5 ml (SD 9.4 ml), and 95% of all differences of measurements were within 1 SD. Interrater correlation was calculated r 0.96 (P 0.001). Neurological and Neuropsychological Assessments All subjects underwent a standardized neurological examination on admission, at days 1 and 4 on the stroke unit, at days 10 to 12 on the ward, and at discharge from the hospital. The neurological deficit was quantified by the use of the National Institutes of Health Stroke Scale (NIHSS). 27 We performed comprehensive neuropsychological examinations in all patients with a first-ever supratentorial stroke event and without any clouding of consciousness or severe disorders of attention (n 23). The neuropsychological examination started with a bedside screening (speech and language, calculation, visuoperceptive and visuoconstructional performance, apraxia, memory, executive functions, and attentional performance) on day 3 after admission. In case of neuropsychological impairments, a comprehensive and standardized neuropsychological evaluation was performed 1 week after admission. In all patients, the functional outcome at discharge was rated with the Barthel score. Statistical data evaluation was performed with nonparametric tests for independent and related samples (Mann-Whitney U, Wilcoxon, and Friedman tests). The threshold for significance was set at P In cases of multiple comparisons, we applied an -adjustment (Bonferroni correction) to compensate for type 1 errors, and only P values 0.01 were considered significant. Results Neuroradiological and Neurobiochemical Data On 55 cranial CT scans, ischemic infarction could be identified corresponding to the acute stroke symptoms; 3 scans showed no clearly demarcated brain infarctions. The lesions in supratentorial stroke mostly involved temporal and parietal brain areas and were mainly supplied by medial and posterior branches of the middle cerebral artery and the lenticulostriate arteries. Seventeen patients showed lesions in the territory of the posterior circulation system. Mean absolute lesion volume was calculated to be 36.6 ml ( 90.2) in supratentorial and 7.6 ml ( 15.3) in infratentorial infarctions. Figure 1 shows the release patterns of protein S-100B and NSE. Maximal protein S-100B concentrations were found on
3 1192 Biochemical Markers Predict Neurobehavioral Outcome After Stroke P 0.057), we found a continuous secondary increase. Volume of lesion and serum concentrations of both neurobiochemical markers were highly and significantly correlated (protein S-100B: t 0 : r , P 0.002; t 1 : r , P 0.001; t 2 : r , P 0.001; t 3 : r , P 0.001; t 4 : r , P 0.001; NSE: t 0 : r , P 0.005; t 1 : r , P 0.021; t 2 : r , P 0.001; t 3 : r , P 0.001; t 4 : r , P 0.001). Both absolute concentrations and temporal patterns of protein S-100B and NSE did not differ significantly with respect to location or vascular supply of the infarcted brain area. Cardioembolism as cause of the brain infarction resulted in significantly higher protein S-100B release compared with small-artery occlusion or large-artery atherosclerosis. Figure 1. Release patterns of protein S-100B (top) and NSE (bottom). Bars indicate medians 95% CI. NSE 0, S-100B 0 indicate serum concentrations soon after admission; NSE 1 4, S-100B 1 4, serum concentrations at days 1 to 4. day 2 on the stroke unit (between 55 and 66 hours after stroke onset). NSE concentrations reached maximal values on the day of admission (between 7 and 18 hours after stroke onset). After a decrease from admission to the end of day 1 on the stroke unit (Wilcoxon signed rank test: z 1.903, TABLE 2. Neuropsychological Deficits in Patients With First Unilateral Supratentorial Infarction Neurological, Neuropsychological, and Functional Outcome NIHSS scores showed a continuous and significant improvement between admission and discharge (Friedman test: , df 5, P 0.001). Detailed neuropsychological assessments 1 week after stroke (mean, days) could be performed in 23 patients with first-ever supratentorial infarctions. Patients with and without neuropsychological assessments did not differ significantly with respect to stroke scale scores, volume of lesion, or serum concentrations of neurobiochemical markers. Fifteen patients (65%) exhibited severe impairments most marked in attentional performance, executive functions, and memory performance (for details, see Table 2). Patients with cerebellar or brain stem lesions showed a better functional outcome at discharge from the hospital (Barthel score, 92 [ 11.6] versus 68.5 [ 37.5] in patients with supratentorial infarctions; P 0.08, Mann-Whitney U test). All LH Lesions RH Lesions No. of patients Age, mean (SD), y 59.2 (14.5) 52.2 (16.8) 65.5 (8.4) Sex, male/female, No. (%) 16 (70)/7 (30) 6 (55)/5 (45) 10 (83)/2 (17) NIHSS score on admission, mean (SD) 7.3 (7.7) 7.7 (6.4) 5.3 (6.9) NIHSS score at discharge, mean (SD) 2.9 (4.5) 1.6 (2.3) 2.8 (3.4) Barthel score at discharge, mean (SD) 86 (26.2) 94 (12.8) 79 (33.4) Lesion volume, mean (SD), ml 11.4 (12.6) 12.8 (14.4) 10.2 (11.2) Neuropsychological deficits, No. (%) 15 (65) 9 (60) 6 (40) Domain of deficits Aphasia 6 (40) 5 (56) 1 (17) Apraxia 3 (20) 2 (22) 1 (17) Visuoperceptive impairment 5 (33) 1 (11) 4 (67) Visuoconstructional impairment 3 (20) 2 (22) 1 (17) Memory impairment 10 (67) 6 (67) 4 (67) Deficits in executive functions 12 (80) 7 (78) 5 (83) Attention deficits 10 (67) 6 (67) 4 (67) LH indicates left hemisphere; RH, right hemisphere.
4 Wunderlich et al June Figure 2. Correlation coefficients between NIHSS scores at discharge and protein S-100B and NSE release. Filled markers indicate P Interactions Between Release of Neurobiochemical Markers and Neurological, Neuropsychological, and Functional Outcome We found high and significant correlations between both neurobiochemical markers and NIHSS scores. Protein S-100B serum concentration began to be significantly associated with neurological status 2 days after the stroke event, and the highest values were found between NIHSS scores at discharge and protein S-100B values at day 4 on the stroke unit (r , P 0.001). Figure 2 shows determination coefficients between both protein S-100B and NSE release and NIHSS scores at discharge. The graph demonstrates that patients with an adverse neurological outcome had a significantly higher and longer release of both markers. The association between release of neurobiochemical markers and neurological status followed the same pattern in patients with supratentorial and infratentorial lesions. Functional outcome (assessed by Barthel score) at discharge from the hospital was significantly correlated with serum concentrations of both neurobiochemical markers 2 to 4 days after admission. Again, the highest correlations were found between late protein S-100B and NSE values and Barthel scores (protein S-100B at day 4: r , P 0.001; NSE at day 4: r , P 0.001). Patients with neuropsychological impairment showed numerically higher protein S-100B concentrations (Figure 3). However, no significant differences between groups could be calculated. NSE values were comparable in both groups. Multivariate analysis based on a stepwise linear regression model with lesion volume, protein S-100B, and NSE concentrations as independent variables and NIHSS score at discharge as dependent variable showed protein S-100B release as the only variable with a significant predictive value. Protein S-100B serum concentration at day 4 after admission (R , 0.82, P 0.001) and protein S-100B at day 1 (R 2 change 0.09, 0.39, P 0.001) explained 75% of the neurological outcome at discharge. Discussion Peak levels of protein S-100B serum concentrations were found at the second day after stroke, whereas a first NSE peak was recorded after admission, followed by a second increase from days 2 to 4. The release patterns of protein S-100B confirm the results of previous clinical studies that had examined sequential S-100B levels after stroke. 6,9,18,28 Experimental data gained from middle cerebral artery occlusion in a rat model showed a significant increase of NSE starting 2 hours after focal ischemia. 4 The different temporal patterns of NSE and protein S-100B release may be attributed to different pathophysiological mechanisms after focal ischemia. NSE serum levels correspond to the ischemia-induced cytoplasmic loss of NSE in neurons and are detectable before irreversible neuronal damage takes place. 11 The first NSE peak within 7 to 18 hours after stroke onset may reflect the initial damage of neuronal tissue, whereas a second increase may be attributed to secondary mechanisms of neuronal damage due to edema and increase of intracranial pressure. In accordance with this assumption, we found a continuous or secondary increase of NSE serum concentrations in 5 of 7 patients with a deterioration of clinical status. The delayed peak level of serum protein S-100B concentration may reflect later responses in the pathophysiological cascade and microglial reaction to ischemia. Both necrotic cell damage in the penumbral zone of focal infarctions and a breakdown of membrane integrity due to cytotoxic and vasogenic edema may provide leakage of protein S-100B from cytosol to the extracellular space. 6,21 We found numerically high and significant correlations between both NSE and protein S-100B serum concentrations and the volume of infarcted brain areas. This result corroborates the data of previous clinical or Figure 3. Protein S-100B release in a subgroup of patients with and without neuropsychological deficits (medians 95% CI).
5 1194 Biochemical Markers Predict Neurobehavioral Outcome After Stroke experimental studies on focal ischemia 5,6,8 10,18,20,21,29 and indicates that both neurobiochemical markers mirror the extent of substantial brain damage. Our data show a significant association between NSE and protein S-100B concentrations and both neurological and functional status at discharge from the hospital. This result could be interpreted as an epiphenomenon of the association between volume of lesion and degree of neurological impairment. However, if the correlation between neurobiochemical parameters and neurological outcome was controlled for the volume of lesion, the partial correlation coefficients dropped but remained significant (protein S-100B at day 4: r , P 0.001). The majority of previous studies failed to demonstrate a significant correlation between NSE release and outcome after stroke Büttner and coworkers 6 reported a significant correlation between protein S-100B and neurological status at admission. They failed, however, to calculate significant correlations between protein S-100B values and the functional outcome 4 weeks after stroke onset. Significant correlations between initial serum and/or cerebrospinal fluid concentrations of protein S-100B and clinical and/or functional outcome were reported by Fassbender et al, 21 Missler et al, 18 and Abraha et al. 5 The comparison of different studies that use protein S-100B as a potential predictor of stroke outcome is hampered by 2 major obstacles. First, the authors used different techniques as well as commercially available or self-developed kits, the sensitivity and specificity of which are not comparable. Second, a variety of different scores and scales were applied for the assessment of neurological status or functional outcome after stroke. Some of the measurements (eg, Glasgow Coma Scale or Glasgow Outcome Scale) are hardly appropriate to provide detailed information on neurological or functional outcome after stroke. In the present study we used a newly developed immunoluminometric assay with a lower detection threshold. Furthermore, we applied more detailed assessments of the neurological, neuropsychological, and functional outcome. Both measurements of serum markers and neurobehavioral assessments provide a wider range of data, which may be responsible for the numerically higher and more significant correlations we found between neurobiochemical and neurobehavioral data. As far as we know, the present study was the first to investigate the release of neurobiochemical markers of brain damage and neuropsychological disorders after stroke. Patients with neuropsychological deficits exhibited numerically higher protein S-100B serum concentrations than patients without neuropsychological impairment. The difference did not reach statistical significance, but we must consider that patients who were not able to perform a standardized neuropsychological assessment were excluded from data analysis. These patients had significantly higher protein S-100B values than patients without neuropsychological deficits and probably will display deficits when neuropsychological assessment can be performed. Protein S-100B and NSE were both associated with neurological and functional outcome at the time of discharge from the hospital. However, a multivariate comparison of release patterns of both markers based on a linear regression analysis demonstrated that only protein S-100B provides significant information on neurological outcome. The same was true with respect to the comparison of neuropsychologically impaired versus unimpaired patients. Protein S-100B therefore seems to have a higher predictive value than NSE. The present studies on neurobiochemical markers in stroke patients concentrate on the relation between release patterns and neurobehavioral disorders. Whether the kinetics of protein S-100B release after brain damage may allow insight into brain repair mechanism or plasticity requires further research. To investigate these questions and to analyze the potential value of neurobiochemical markers with respect to subtle long-term neuropsychological deficits, studies with a neuropsychological follow-up examination are needed. Acknowledgments The authors are greatly indebted to C.-W. Wallesch, MD, for allowing access to patients under his care, W. Döhring, MD, for making available the original cranial CT and MRI data, and the staff of the stroke unit for extensive collaboration. Kits for the analysis of protein S-100B and NSE were provided by Byk-Sangtec Diagnostica, Dietzenbach, Germany. References 1. Schäfer BW, Heizmann CW. The S100 family of EF-hand calciumbinding proteins: function and pathology. Trends Biochem Sci. 1996;21: Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function, and expression. Brain Res Bull. 1995;37: Marangos PJ. Neuron specific enolase: a clinically useful marker of neurons and neuroendocrine cells. Annu Rev Neurosci. 1987;10: Barone FC, Clark RK, Price WJ, White RF, Feuerstein GZ, Storer BL, Ohlstein EH. Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia. Brain Res. 1993;623: Abraha HD, Butterworth RJ, Bath PMW, Wassif WS, Garthwaite J, Sherwood RA. Serum S-100 protein: relationship to clinical outcome in acute stroke. Ann Clin Biochem. 1997;34: Büttner T, Weyers S, Postert T, Sprengelmeyer R, Kuhn W. S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke. 1997;28: Butterworth RJ, Wassif WS, Sherwood RA, Gerges A, Poyser KH, Garthwaite J, Peters TJ, Bath PMW. Serum neuron-specific enolase, carnosinase, and their ratio in acute stroke. Stroke. 1996;27: Cunningham RT, Watt M, Winder J, McKinstry S, Lawson JT, Johnston CF, Hawkins SA, Buchanan KD. Serum neurone-specific enolase as an indicator of stroke volume. Eur J Clin Invest. 1996;26: Hårdemark HG, Ericsson N, Kotwica Z, Rundström G, Mendel-Hartvig I, Olsson Y, Påhlman S, Persson L. S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage. J Neurosurg. 1989;71: Hatfield RH, McKernan RM. CSF neuron-specific enolase as a quantitative marker of neuronal damage in a rat model. Brain Res. 1992;577: Horn M, Seger F, Schlote W. Neuron-specific enolase in gerbil brain and serum after transient cerebral ischemia. Stroke. 1995;26: Ingebrigtsen T, Romner B, Trumpy JH. Management of minor head injury: the value of early computed tomography and serum protein S-100 measurements. J Clin Neurosci. 1997;4: Woertgen C, Rothoerl RD, Holzschuh M, Metz C, Brawanski A. Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neurochir (Wien). 1997;139: Herrmann M, Curio N, Jost S, Wunderlich MT, Synowitz H, Wallesch CW. Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury. Restor Neurol Neurosci. 1999;14: Aberg T. Signs of brain cell injury during open heart operations: past and present. Ann Thorac Surg. 1995;59: Blomquist S, Johnsson P, Lührs C, Malmkvist G, Solem JO, Alling C, Stahl E. The appearance of S-100 protein in serum during and immediately after cardiopulmonary bypass surgery: a possible marker for cerebral injury. J Cardiothorac Vasc Anesth. 1997;11:
6 Wunderlich et al June Rosén H, Rosengren L, Herlitz J, Blomstrand C. Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. Stroke. 1998;29: Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuronspecific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke. 1997;28: Schaarschmidt H, Prange HW, Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke. 1994;24: Cunningham RT, Young IS, Winder J, O Kane MJ, McKinstry S, Johnston CF, Dolan OM, Hawkins SA, Buchanan KD. Serum neuron specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest. 1991; 21: Fassbender K, Schmidt R, Schreiner A, Fatar M, Mühlhauser F, Daffertshofer M, Hennerici M. Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. J Neurol Sci. 1997;148: Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1999;337: Adams HP, Bendixen BH, Kappelle J, Biller J, Love BB, Gordon DL, Marsh EE III, and the TOAST Investigators. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke. 1993;24: Damasio H, Damasio AR. Lesion Analysis in Neuropsychology. New York, NY: Oxford University Press; Matsui T, Hirano A. An Atlas of the Human Brain for Computerized Tomography. Stuttgart, Germany: Gustav Fischer Verlag; Ghika JA, Bogousslavsky J, Regli F. Deep perforators from the carotid system: template of the vascular territories. Arch Neurol. 1990;47: Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, Rorick M, Moomaw CJ, Walker M. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20: Kim JS, Yoon SS, Kim YH, Ryu JS. Serial measurement of interleukin-6, transforming growth factor-, and S-100 protein in patients with acute stroke. Stroke. 1996;27: Aurell A, Rosengren LE, Karlsson B, Olsson JE, Zbornikova V, Haglid KG. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke. 1991;22:
ORIGINAL CONTRIBUTION
ORIGINAL CONTRIBUTION Evaluation of Serum S0B as a Surrogate Marker for Long-term Outcome and Infarct Volume in Acute Middle Cerebral Artery Infarction Christian Foerch, MD; Oliver C. Singer, MD; Tobias
More informationLocalizing lesion locations to predict extent of aphasia recovery. Abstract
Localizing lesion locations to predict extent of aphasia recovery Abstract Extensive research has related specific lesion locations to language impairment in aphasia. However, far less work has focused
More informationM Herrmann, N Curio, S Jost, C Grubich, A D Ebert, M L Fork, H Synowitz. release patterns of neurobiochemical
J Neurol Neurosurg Psychiatry 2001;70:95 100 95 Division of Neuropsychology and Behavioral Neurology, Faculty of Medicine, Otto-von-Guericke- University, Leipzigerstraβe 44, 39120 Magdeburg, Germany M
More informationNeurological Features and Mechanisms of Acute Bilateral Cerebellar Infarction
Neurological Features and Mechanisms of Acute Bilateral Cerebellar Infarction Ji-Man Hong, M.D., Sang Geon Shin, M.D., Jang-Sung Kim, M.D., Oh-Young Bang, M.D., In-Soo Joo, M.D., Kyoon-Huh, M.D. Department
More informationIschemic Stroke in Critically Ill Patients with Malignancy
Ischemic Stroke in Critically Ill Patients with Malignancy Jeong-Am Ryu 1, Oh Young Bang 2, Daesang Lee 1, Jinkyeong Park 1, Jeong Hoon Yang 1, Gee Young Suh 1, Joongbum Cho 1, Chi Ryang Chung 1, Chi-Min
More informationPrognostic value of somatosensory evoked potentials, neuron-specific enolase, and S100 for short-term outcome in ischemic stroke
J Neurophysiol :,. First published December, ; doi:./jn... Prognostic value of somatosensory evoked potentials, neuron-specific enolase, and S for short-term outcome in ischemic stroke Walter F. Haupt,
More informationStroke: clinical presentations, symptoms and signs
Stroke: clinical presentations, symptoms and signs Professor Peter Sandercock University of Edinburgh EAN teaching course Burkina Faso 8 th November 2017 Clinical diagnosis is important to Ensure stroke
More information[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]
2015 PHYSICIAN SIGN-OFF (1) STUDY NO (PHY-1) CASE, PER PHYSICIAN REVIEW 1=yes 2=no [strictly meets case definition] (PHY-1a) CASE, IN PHYSICIAN S OPINION 1=yes 2=no (PHY-2) (PHY-3) [based on all available
More informationCT and MR Imaging in Young Stroke Patients
CT and MR Imaging in Young Stroke Patients Ashfaq A. Razzaq,Behram A. Khan,Shahid Baig ( Department of Neurology, Aga Khan University Hospital, Karachi. ) Abstract Pages with reference to book, From 66
More informationStroke School for Internists Part 1
Stroke School for Internists Part 1 November 4, 2017 Dr. Albert Jin Dr. Gurpreet Jaswal Disclosures I receive a stipend for my role as Medical Director of the Stroke Network of SEO I have no commercial
More informationAn increasing proportion of patients who suffer out-ofhospital
Increased Serum Levels of the S-100 Protein Are Associated With Hypoxic Brain Damage After Cardiac Arrest H. Rosén, MD; L. Rosengren, MD, PhD; J. Herlitz, MD, PhD; C. Blomstrand, MD, PhD Background and
More informationBlood Supply. Allen Chung, class of 2013
Blood Supply Allen Chung, class of 2013 Objectives Understand the importance of the cerebral circulation. Understand stroke and the types of vascular problems that cause it. Understand ischemic penumbra
More informationThe term minor stroke is often used for stroke patients
What Is a Minor Stroke? Urs Fischer, MD, MSc; Adrian Baumgartner, MS; Marcel Arnold, MD; Krassen Nedeltchev, MD; Jan Gralla, MD, MSc; Gian Marco De Marchis, MD; Liliane Kappeler, MD; Marie-Luise Mono,
More informationHow well does the Oxfordshire Community Stroke Project classification predict the site and size of the infarct on brain imaging?
558 Neurosciences Trials Unit, Department of Clinical Neurosciences, Western General Hospital, Edinburgh EH4 2XU, UK G E Mead S C Lewis J M Wardlaw M S Dennis C P Warlow Correspondence to: Dr S C Lewis,
More informationPrognostic Value of the Hyperdense Middle Cerebral Artery Sign and Stroke Scale Score before Ultraearly Thrombolytic Therapy
Prognostic Value of the Hyperdense Middle Cerebral Artery Sign and Stroke Scale Score before Ultraearly Thrombolytic Therapy Thomas Tomsick, Thomas Brott, William Barsan, Joseph Broderick, E. Clarke Haley,
More informationClinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease
Cronicon OPEN ACCESS EC NEUROLOGY Research Article Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Jin Ok Kim, Hyung-IL Kim, Jae Guk Kim, Hanna Choi, Sung-Yeon
More informationStroke/Carotid Artery Disease Outcome Detail (Form 121/132, CaD ppts)
This file contains outcomes collected through the end of Ext1. ID WHI Participant Common ID Col#1 N Missing 0 ASCSOURCE Ascertainment Source Col#2 1 Local Form 121 241 14.9 2 Central Form 121 112 6.9 3
More informationAcute stroke. Ischaemic stroke. Characteristics. Temporal classification. Clinical features. Interpretation of Emergency Head CT
Ischaemic stroke Characteristics Stroke is the third most common cause of death in the UK, and the leading cause of disability. 80% of strokes are ischaemic Large vessel occlusive atheromatous disease
More informationRedgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on
6. Imaging in TIA 6.1 What type of brain imaging should be used in suspected TIA? 6.2 Which patients with suspected TIA should be referred for urgent brain imaging? Evidence Tables IMAG1: After TIA/minor
More informationPure Motor Hemiparesis and Sensorimotor Stroke. Accuracy of Very Early Clinical Diagnosis of Lacunar Strokes
92 Pure Motor Hemiparesis and Sensorimotor Accuracy of Very Early Clinical Diagnosis of Lacunar s Danilo Toni, MD, PhD; Rita Del Duca, MD; Marco Fiorelli, MD, PhD; Maria Luisa Sacchetti, MD; Stefano Bastianello,
More informationSeveral studies have suggested that short-term stroke risk
Poststroke Neurological Improvement Within 7 Days Is Associated With Subsequent Deterioration Stella Aslanyan, MD; Christopher J. Weir, PhD; S. Claiborne Johnston, MD, PhD; Kennedy R. Lees, MD, FRCP; for
More informationStroke/Carotid Artery Disease Outcome Detail (Form 121/132)
In Ext2 these outcomes are only adjudicated for Medical Record Cohort (MRC) ppts. ID WHI Participant Common ID Col#1 ASCSOURCE Ascertainment Source Col#2 1 Local Form 121 1,112 14.4 2 Central Form 121
More informationThe Impact of Smoking on Acute Ischemic Stroke
Smoking The Impact of Smoking on Acute Ischemic Stroke Wei-Chieh Weng, M.D. Department of Neurology, Chang-Gung Memorial Hospital, Kee-Lung, Taiwan Smoking related mortality Atherosclerotic vascular disease
More informationA trial fibrillation (AF) is a common arrhythmia that is
679 PAPER Atrial fibrillation as a predictive factor for severe stroke and early death in 15 831 patients with acute ischaemic stroke K Kimura, K Minematsu, T Yamaguchi, for the Japan Multicenter Stroke
More informationGlobal aphasia without hemiparesis: language profiles and lesion distribution
J Neurol Neurosurg Psychiatry 1999;66:365 369 365 Department of Neurology, Washington University School of Medicine, DC, USA R E Hanlon W E Lux A W Dromerick Correspondence to: Dr Robert Hanlon, Department
More information11/27/2017. Stroke Management in the Neurocritical Care Unit. Conflict of interest. Karel Fuentes MD Medical Director of Neurocritical Care
Stroke Management in the Neurocritical Care Unit Karel Fuentes MD Medical Director of Neurocritical Care Conflict of interest None Introduction Reperfusion therapy remains the mainstay in the treatment
More informationEssentials of Clinical MR, 2 nd edition. 14. Ischemia and Infarction II
14. Ischemia and Infarction II Lacunar infarcts are small deep parenchymal lesions involving the basal ganglia, internal capsule, thalamus, and brainstem. The vascular supply of these areas includes the
More informationMeasurements of Acute Cerebral Infarction: Lesion Size by Computed Tomography
87 Measurements of Acute Cerebral Infarction: Lesion Size by Computed Tomography Thomas Brott, MD, John R. Marler, MD, Charles P. Olinger, MD, Harold P. Adams Jr., MD, Thomas Tomsick, MD, William G. Barsan,
More informationCHAPTER 5. Symptomatic and Asymptomatic Retinal Embolism Have Different Mechanisms
CHAPTER 5 Symptomatic and Asymptomatic Retinal Embolism Have Different Mechanisms Christine A.C. Wijman, Joao A. Gomes, Michael R. Winter, Behrooz Koleini, Ippolit C.A. Matjucha, Val E. Pochay, Viken L.
More informationComputed tomography (CT) is now used routinely
506 Computed Tomography in Prognostic Stroke Evaluation D. Rasmussen, MD; O. Kohler, MD; S. Worm-Petersen, MD; N. Blegvad, MD; H.L. Jacobsen, MSc; I. Bergmann, MD; M. Egeblad, MD; M. Friis, MD; and N.T.
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Kang D-H, Kim Y-J, Kim S-H, et al. Early surgery versus conventional
More informationSupratentorial cerebral arteriovenous malformations : a clinical analysis
Original article: Supratentorial cerebral arteriovenous malformations : a clinical analysis Dr. Rajneesh Gour 1, Dr. S. N. Ghosh 2, Dr. Sumit Deb 3 1Dept.Of Surgery,Chirayu Medical College & Research Centre,
More informationSerum biomarkers for predicting outcome after TBI
Józef Opara, Andrzej Małecki, Elżbieta Małecka Serum biomarkers for predicting outcome after TBI Jerzy Kukuczka Academy of Physical Education in Katowice TBI biomarkers A biomarker, or biological marker,
More informationIMAGING IN ACUTE ISCHEMIC STROKE
IMAGING IN ACUTE ISCHEMIC STROKE Timo Krings MD, PhD, FRCP (C) Professor of Radiology & Surgery Braley Chair of Neuroradiology, Chief and Program Director of Diagnostic and Interventional Neuroradiology;
More informationNeurological outcomes and mortality in patients with type A aortic dissection. Impact of intra-operative management
Neurological outcomes and mortality in patients with type A aortic dissection. Impact of intra-operative management P Santé, M. Buonocore L Majello, A Caiazzo, G Petrone, G Nappi Dept. of Cardiothoracic
More informationPopulation-Based Study of Determinants of Initial Secondary Care Costs of Acute Stroke in the United Kingdom
Population-Based Study of Determinants of Initial Secondary Care Costs of Acute Stroke in the United Kingdom Ramon Luengo-Fernandez, MSc; Alastair M. Gray, PhD; Peter M. Rothwell, FRCP Background and Purpose
More informationClinical Outcome of Borderline Subdural Hematoma with 5-9 mm Thickness and/or Midline Shift 2-5 mm
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2017/300 Clinical Outcome of Borderline Subdural Hematoma with 5-9 mm Thickness and/or Midline Shift 2-5 mm Raja S Vignesh
More informationSUPERVISORS: PROF E. AMAYO, CONSULTANT NEUROLOGIST, ASSOCIATE PROFESSOR OF MEDICINE DEPT. OF CLINICAL MEDICINE AND THERAPEUTICS - UoN DR MECHA,CONSULT
30-DAY OUTCOME OF STROKE IN PATIENTS AT KENYATTA NATIONAL HOSPITAL. DR ANDREW KAMAU NDARA PHYSICIAN MBChB, Mmed 26/11/11 K.A.P MEETING K.I.C.C SUPERVISORS: PROF E. AMAYO, CONSULTANT NEUROLOGIST, ASSOCIATE
More informationThe Importance of Middle Cerebral Artery Stenosis In Patients With A Lacunar Infarction In The Carotid Artery Territory
The Importance of Middle Cerebral Artery Stenosis In Patients With A Lacunar Infarction In The Carotid Artery Territory Oh Young Bang, M.D., Jeong Hoon Cho, M.D., Ji Hoe Heo, M.D., Dong Ik Kim, M.D.* Department
More informationNEURORADIOLOGY DIL part 4
NEURORADIOLOGY DIL part 4 Strokes and infarcts K. Agyem MD, G. Hall MD, D. Palathinkal MD, Alexandre Menard March/April 2015 OVERVIEW Introduction to Neuroimaging - DIL part 1 Basic Brain Anatomy - DIL
More informationIntroduction. Abstract. Michael Yannes 1, Jennifer V. Frabizzio, MD 1, and Qaisar A. Shah, MD 1 1
Reversal of CT hypodensity after acute ischemic stroke Michael Yannes 1, Jennifer V. Frabizzio, MD 1, and Qaisar A. Shah, MD 1 1 Abington Memorial Hospital in Abington, Pennsylvania Abstract We report
More informationAdvances in the treatment of posterior cerebral circulation symptomatic disease
Advances in the treatment of posterior cerebral circulation symptomatic disease Athanasios D. Giannoukas MD, MSc(Lond.), PhD(Lond.), FEBVS Professor of Vascular Surgery Faculty of Medicine, School of Health
More informationComplete Recovery of Perfusion Abnormalities in a Cardiac Arrest Patient Treated with Hypothermia: Results of Cerebral Perfusion MR Imaging
pissn 2384-1095 eissn 2384-1109 imri 2018;22:56-60 https://doi.org/10.13104/imri.2018.22.1.56 Complete Recovery of Perfusion Abnormalities in a Cardiac Arrest Patient Treated with Hypothermia: Results
More informationOriginal Article Serum somatostatin and neuron-specific enolase might be biochemical markers of vascular dementia in the early stage
Int J Clin Exp Med 2015;8(10):19471-19475 www.ijcem.com /ISSN:1940-5901/IJCEM0012679 Original Article Serum somatostatin and neuron-specific enolase might be biochemical markers of vascular dementia in
More information/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis
Multi-Ethnic Study of Atherosclerosis Participant ID: Hospital Code: Hospital Abstraction: Stroke/TIA History and Hospital Record 1. Was the participant hospitalized as an immediate consequence of this
More informationThe Oxfordshire Community Stroke Project (OCSP) devised
Relationship Between Pattern of Intracranial Artery Abnormalities on Transcranial Doppler and Oxfordshire Community Stroke Project Clinical Classification of Ischemic Stroke G.E. Mead, MD; J.M. Wardlaw,
More informationStroke/TIA. Tom Bedwell
Stroke/TIA Tom Bedwell tab1g11@soton.ac.uk The Plan Definitions Anatomy Recap Aetiology Pathology Syndromes Brocas / Wernickes Investigations Management Prevention & Prognosis TIAs Key Definitions Transient
More informationClinical Study Circle of Willis Variants: Fetal PCA
Stroke Research and Treatment Volume 2013, Article ID 105937, 6 pages http://dx.doi.org/10.1155/2013/105937 Clinical Study Circle of Willis Variants: Fetal PCA Amir Shaban, 1 Karen C. Albright, 2,3,4,5
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Cognitive impairment evaluated with Vascular Cognitive Impairment Harmonization Standards in a multicenter prospective stroke cohort in Korea Supplemental Methods Participants From
More informationIMAGING IN ACUTE ISCHEMIC STROKE
IMAGING IN ACUTE ISCHEMIC STROKE Timo Krings MD, PhD, FRCP (C) Professor of Radiology & Surgery Braley Chair of Neuroradiology, Chief and Program Director of Diagnostic and Interventional Neuroradiology;
More informationACUTE STROKE IMAGING
ACUTE STROKE IMAGING Mahesh V. Jayaraman M.D. Director, Inter ventional Neuroradiology Associate Professor Depar tments of Diagnostic Imaging and Neurosurger y Alper t Medical School at Brown University
More informationPAPER F National Collaborating Centre for Chronic Conditions at the Royal College of Physicians
6.3 Early carotid imaging in acute stroke or TIA Evidence Tables IMAG4: Which patients with suspected stroke/tia should be referred for urgent carotid imaging? Reference Ahmed AS, Foley E, Brannigan AE
More informationStroke - Intracranial hemorrhage. Dr. Amitesh Aggarwal Associate Professor Department of Medicine
Stroke - Intracranial hemorrhage Dr. Amitesh Aggarwal Associate Professor Department of Medicine Etiology and pathogenesis ICH accounts for ~10% of all strokes 30 day mortality - 35 45% Incidence rates
More informationCorrelation between Intracerebral Hemorrhage Score and surgical outcome of spontaneous intracerebral hemorrhage
Bangladesh Med Res Counc Bull 23; 39: -5 Correlation between Intracerebral Hemorrhage Score and surgical outcome of spontaneous intracerebral hemorrhage Rashid HU, Amin R, Rahman A, Islam MR, Hossain M,
More informationStroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%
Stroke Update Michel Torbey, MD, MPH, FAHA, FNCS Medical Director, Neurovascular Stroke Center Professor Department of Neurology and Neurosurgery The Ohio State University Wexner Medical Center Objectives
More informationSilent Infarction in Patients with First-ever Stroke
221 Silent Infarction in Patients with First-ever Stroke Cheung-Ter Ong 1, Wen-Pin Chen 2, Sheng-Feng Sung 1, Chi-Shun Wu 1, and Yung-Chu Hsu 1 Abstract- Background / Purpose: Silent infarcts (SIs) are
More informationCharacteristic features of CNS pathology. By: Shifaa AlQa qa
Characteristic features of CNS pathology By: Shifaa AlQa qa Normal brain: - The neocortex (gray matter): six layers: outer plexiform, outer granular, outer pyramidal, inner granular, inner pyramidal, polymorphous
More informationSpeakers. 2015, American Heart Association 1
Speakers Lee Schwamm, MD, FAHA Executive Vice Chairman of Neurology, Massachusetts General Hospital Director, Stroke Service and Medical Director, MGH TeleHealth, Massachusetts General Hospital Director,
More informationKettunen Jani E, Nurmi Mari, Koivisto Anna-Maija, Dastidar Prasun, Jehkonen Mervi Name of article:
This document has been downloaded from Tampub The Institutional Repository of University of Tampere Publisher's version Authors: Kettunen Jani E, Nurmi Mari, Koivisto Anna-Maija, Dastidar Prasun, Jehkonen
More informationCerebro-vascular stroke
Cerebro-vascular stroke CT Terminology Hypodense lesion = lesion of lower density than the normal brain tissue Hyperdense lesion = lesion of higher density than normal brain tissue Isodense lesion = lesion
More informationMedicine. Neuron-Specific Enolase, S100 Calcium-Binding Protein B, and Heat Shock Protein 70 Levels in Patients With Intracranial Hemorrhage
Medicine OBSERVATIONAL STUDY Neuron-Specific Enolase, S100 Calcium-Binding Protein B, and Heat Shock Protein 70 Levels in Patients With Intracranial Hemorrhage Ömer Doğan Alatas, MD, Mehtap Gürger, MD,
More informationCerebrovascular Disorders. Blood, Brain, and Energy. Blood Supply to the Brain 2/14/11
Cerebrovascular Disorders Blood, Brain, and Energy 20% of body s oxygen usage No oxygen/glucose reserves Hypoxia - reduced oxygen Anoxia - Absence of oxygen supply Cell death can occur in as little as
More informationCNS pathology Third year medical students. Dr Heyam Awad 2018 Lecture 5: disturbed fluid balance and increased intracranial pressure
CNS pathology Third year medical students Dr Heyam Awad 2018 Lecture 5: disturbed fluid balance and increased intracranial pressure ILOs Understand causes and symptoms of increased intracranial pressure.
More informationClinical Features of Patients Who Come to Hospital at the Super Acute Phase of Stroke
Research Article imedpub Journals http://www.imedpub.com Clinical Features of Patients Who Come to Hospital at the Super Acute Phase of Stroke Abstract Background: The number of patients who are adopted
More informationIV. Cerebrovascular diseases
IV. Cerebrovascular diseases - Cerebrovascular disease denotes brain disorders caused by pathologic processes involving the blood vessels. - The three main pathogenic mechanisms are: 1. Thrombotic occlusion
More informationCLINICAL FEATURES THAT SUPPORT ATHEROSCLEROTIC STROKE 1. cerebral cortical impairment (aphasia, neglect, restricted motor involvement, etc.) or brain stem or cerebellar dysfunction 2. lacunar clinical
More informationThe National Institutes of Health Stroke Scale (NIHSS)
National Institutes of Health Stroke Scale Score and Vessel Occlusion in 252 Patients With Acute Ischemic Stroke Mirjam R. Heldner, MD; Christoph Zubler, MD; Heinrich P. Mattle, MD; Gerhard Schroth, MD;
More informationDisclosures. An Update on TIA and Minor Stroke. The Agenda PROGNOSIS PATHOPHYSIOLOGY GUIDELINES AND PROVEN MANAGEMENT STRATEGIES AGGRESSIVE TREATMENT
Disclosures An Update on TIA and Minor Stroke Dr. Johnston is principal investigator for the POINT trial, sponsored by the NIH but with drug and placebo contributed by Sanofi-Aventis. S. Claiborne Johnston,
More informationImaging Biomarkers Significance S100B NSE. Admitted within 6 hours of injury and CT scan occurred after initial examination. N = 1,064 CT+ N = 50 4.
Concussion Guidelines Step 1: Systematic Review of Prevalent Indicators Supplemental Content 7 Evidence Table. Included Studies For Key Question 4 Imaging and Biomarker Publications Medium Potential for
More informationIntensive Medical Therapy with Therapeutic Hypothermia for Malignant Middle Cerebral Artery Infarction
Intensive Medical Therapy with Therapeutic Hypothermia for Malignant Middle Cerebral Artery Infarction Kyu sun Lee 1, Sung Eun Lee, 1 Jin Soo Lee 1, Ji Man Hong 1 1 Department of Neurology, Ajou University
More informationSpontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke
Original Contribution Spontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke Abstract Introduction: Acute carotid artery occlusion carries
More informationEarly Neurologic Deterioration after Stroke Depends on Vascular Territory and Stroke Etiology
Journal of Stroke 2016;18(2):203-210 Original Article Early Neurologic Deterioration after Stroke Depends on Vascular Territory and Stroke Etiology James E. Siegler, Alyana Samai, Eleanor Semmes, Sheryl
More informationACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS. Justin Nolte, MD Assistant Profession Marshall University School of Medicine
ACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS Justin Nolte, MD Assistant Profession Marshall University School of Medicine History of Presenting Illness 64 yo wf with PMHx of COPD, HTN, HLP who was in
More informationProfiles of the National Institutes of Health Stroke Scale Items as a Predictor of Patient Outcome
Profiles of the National Institutes of Health Stroke Scale Items as a Predictor of Patient Outcome Heidi Sucharew, PhD; Jane Khoury, PhD; Charles J. Moomaw, PhD; Kathleen Alwell, BSN; Brett M. Kissela,
More informationThere is no gold standard for the diagnosis of
1220 Original Contributions Silent Stroke in Patients With Transient Ischemic Attack or Minor Ischemic Stroke D. Herderschee, MD; A. Hijdra, MD; A. Algra, MD; P.J. Koudstaal, MD; L.J. Kappelle, MD; and
More informationClinical Analysis of Risk Factors Affecting Rebleeding in Patients with an Aneurysm. Gab Teug Kim, M.D.
/ 119 = Abstract = Clinical Analysis of Risk Factors Affecting Rebleeding in Patients with an Aneurysm Gab Teug Kim, M.D. Department of Emergency Medicine, College of Medicine, Dankook University, Choenan,
More informationLongitudinal anterior-to-posterior shift of collateral channels in patients with moyamoya disease: an implication for its hemorrhagic onset
CLINICAL ARTICLE Longitudinal anterior-to-posterior shift of collateral channels in patients with moyamoya disease: an implication for its hemorrhagic onset Shusuke Yamamoto, MD, Satoshi Hori, MD, PhD,
More informationORIGINAL CONTRIBUTION. Multiphasic Helical Computed Tomography Predicts Subsequent Development of Severe Brain Edema in Acute Ischemic Stroke
ORIGINAL CONTRIBUTION Multiphasic Helical Computed Tomography Predicts Subsequent Development of Severe Brain Edema in Acute Ischemic Stroke Soo Joo Lee, MD; Kwang Ho Lee, MD; Dong Gyu Na, MD; Hong Sik
More informationMalignant Edema and Hemicraniectomy After Stroke
Malignant Edema and Hemicraniectomy After Stroke Sherri A. Braksick, MD March 29, 2017 No Financial Disclosures No Discussion of Off-Label Usage Objectives 1. Review the pathophysiology of edema after
More informationCEREBROVASCULAR DISEASES. By: Shifaa AlQa qa
CEREBROVASCULAR DISEASES By: Shifaa AlQa qa Cerebrovascular diseases Brain disorders caused by pathologic processes involving blood vessels 3 pathogenic mechanisms (1) thrombotic occlusion, (2) embolic
More informationRisk Factors for Ischemic Stroke: Electrocardiographic Findings
Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead
More informationEarly Hospitalization of Patients with TIA: A Prospective, Population-based Study
Early Hospitalization of Patients with TIA: A Prospective, Population-based Study Mohamed Al-Khaled, MD, and J urgen Eggers, MD Background: The German Stroke Society (GSS) recommends early hospitalization
More informationMedical Neuroscience Tutorial Notes
Medical Neuroscience Tutorial Notes Blood Supply to the Brain MAP TO NEUROSCIENCE CORE CONCEPTS 1 NCC1. The brain is the body's most complex organ. LEARNING OBJECTIVES After study of the assigned learning
More informationACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke
ACUTE ISCHEMIC STROKE Current Treatment Approaches for Acute Ischemic Stroke EARLY MANAGEMENT OF ACUTE ISCHEMIC STROKE Rapid identification of a stroke Immediate EMS transport to nearest stroke center
More information11/23/2015. Disclosures. Stroke Management in the Neurocritical Care Unit. Karel Fuentes MD Medical Director of Neurocritical Care.
Stroke Management in the Neurocritical Care Unit Karel Fuentes MD Medical Director of Neurocritical Care Disclosures I have no relevant commercial relationships to disclose, and my presentations will not
More information정진일 외 : 일과성 허혈성 발작의 확산 강조MR영상
17 A B Fig. 1. A 71 year-old male patient was complained of abrupt motor weakness of extremities, lasting about 3-4 hours. He was diagnosed as TIA (transient ischemic attack) with full recovery of neurologic
More informationErwin Stolz, Tibo Gerriets, Ingo Fiss, Sait S. Babacan, Günter Seidel, and Manfred Kaps. AJNR Am J Neuroradiol 20: , September 1999
AJNR Am J Neuroradiol 20:1567 1571, September 1999 Comparison of Transcranial Color-Coded Duplex Sonography and Cranial CT Measurements for Determining Third Ventricle Midline Shift in Space-Occupying
More informationx = ( A) + (3.296 B) (0.070 C) (1.006 D) + (2.426 E) Receiver Operating Characteristic ROC
7 1... 4. 5. 6. 7. 8. 9. 1. 000 1 01 11 006 01 1 11 6 Glasgow outcome scale GOS GOS 4 n=477 55 A C D 5 ph B E = 1/(1 + e x) x = ( 0.0 A) + (.96 B) (0.070 C) (1.006 D) + (.46 E) 19.489 estimated probability
More informationPearls and Pitfalls in Neuroradiology of Cerebrovascular Disease The Essentials with MR and CT
Pearls and Pitfalls in Neuroradiology of Cerebrovascular Disease The Essentials with MR and CT Val M. Runge, MD Wendy R. K. Smoker, MD Anton Valavanis, MD Control # 823 Purpose The focus of this educational
More informationPerils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion
Perils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion Aman B. Patel, MD Robert & Jean Ojemann Associate Professor Director, Cerebrovascular Surgery Director, Neuroendovascular
More informationElectroencephalography Improves the Prediction of Functional Outcome in the Acute Stage of Cerebral Ischemia
1968 Electroencephalography Improves the Prediction of Functional Outcome in the Acute Stage of Cerebral Ischemia J.P.M. Cillessen, MD; A.C. van Huffelen, MD; LJ. Kappelle, MD; A. Algra, MD; J. van Gijn,
More informationDoes Use of the Recognition Of Stroke In the Emergency Room Stroke Assessment Tool Enhance Stroke Recognition by Ambulance Clinicians?
Does Use of the Recognition Of Stroke In the Emergency Room Stroke Assessment Tool Enhance Stroke Recognition by Ambulance Clinicians? Rachael T. Fothergill, PhD; Julia Williams, PhD; Melanie J. Edwards,
More informationThrombus Localization with Emergency Cerebral CT
Thrombus Localization with Emergency Cerebral CT Thomas Tomsick, ' Thomas Brott, William Barsan, Joseph Broderick, E. Clarke Haley, and Judith Spilker Purpose: To determine the prevalence of the hyperdense
More informationIcd 10 parietal stroke
P ford residence southampton, ny Icd 10 parietal stroke GO Icd 10 code for parietal stroke Approximate Synonyms. Cerebrovascular accident due to left middle cerebral artery occlusion; Left middle cerebral
More informationInside Your Patient s Brain Michelle Peterson, APRN, CNP Centracare Stroke and Vascular Neurology
Inside Your Patient s Brain Michelle Peterson, APRN, CNP Centracare Stroke and Vascular Neurology Activity Everyone stand up, raise your right hand, tell your neighbors your name 1 What part of the brain
More informationTHE ESSENTIAL BRAIN INJURY GUIDE
THE ESSENTIAL BRAIN INJURY GUIDE Neuroanatomy & Neuroplasticity Section 2 Contributors Erin D. Bigler, PhD Michael R. Hoane, PhD Stephanie Kolakowsky-Hayner, PhD, CBIST, FACRM Dorothy A. Kozlowski, PhD
More information